SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-12-151451
Filing Date
2012-04-05
Accepted
2012-04-05 12:49:14
Documents
3
Group Members
CAROLINA PHARMACEUTICALS HOLDINGS, LTD.CAROLINA PHARMACEUTICALS LTD.CRAIG A. COLLARD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 5 d329606dsc13da.htm SC 13D/A 134412
2 JOINT FILING AGREEMENT d329606dex1009.htm EX-10.09 7740
3 STOCK PURCHASE AGREEMENT d329606dex1017.htm EX-10.17 85171
  Complete submission text file 0001193125-12-151451.txt   229217
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Subject) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79887 | Film No.: 12744729
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
Cornerstone BioPharma Holdings, Ltd. (Filed by) CIK: 0001434508 (see all company filings)

IRS No.: 201586225 | State of Incorp.: 1A | Fiscal Year End: 1231
Type: SC 13D/A